1. Home
  2. PRCT vs RUM Comparison

PRCT vs RUM Comparison

Compare PRCT & RUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • RUM
  • Stock Information
  • Founded
  • PRCT 2009
  • RUM 2013
  • Country
  • PRCT United States
  • RUM United States
  • Employees
  • PRCT N/A
  • RUM N/A
  • Industry
  • PRCT Medical Specialities
  • RUM Computer Software: Prepackaged Software
  • Sector
  • PRCT Health Care
  • RUM Technology
  • Exchange
  • PRCT Nasdaq
  • RUM Nasdaq
  • Market Cap
  • PRCT 3.2B
  • RUM N/A
  • IPO Year
  • PRCT 2021
  • RUM N/A
  • Fundamental
  • Price
  • PRCT $58.79
  • RUM $7.21
  • Analyst Decision
  • PRCT Strong Buy
  • RUM Buy
  • Analyst Count
  • PRCT 7
  • RUM 3
  • Target Price
  • PRCT $94.29
  • RUM $15.00
  • AVG Volume (30 Days)
  • PRCT 904.1K
  • RUM 2.6M
  • Earning Date
  • PRCT 04-24-2025
  • RUM 03-25-2025
  • Dividend Yield
  • PRCT N/A
  • RUM N/A
  • EPS Growth
  • PRCT N/A
  • RUM N/A
  • EPS
  • PRCT N/A
  • RUM N/A
  • Revenue
  • PRCT $224,498,000.00
  • RUM $95,488,190.00
  • Revenue This Year
  • PRCT $46.28
  • RUM $21.77
  • Revenue Next Year
  • PRCT $32.67
  • RUM $35.89
  • P/E Ratio
  • PRCT N/A
  • RUM N/A
  • Revenue Growth
  • PRCT 64.84
  • RUM 17.94
  • 52 Week Low
  • PRCT $45.56
  • RUM $4.92
  • 52 Week High
  • PRCT $103.81
  • RUM $17.40
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 43.67
  • RUM 35.90
  • Support Level
  • PRCT $56.14
  • RUM $7.65
  • Resistance Level
  • PRCT $64.38
  • RUM $8.47
  • Average True Range (ATR)
  • PRCT 2.76
  • RUM 0.45
  • MACD
  • PRCT 0.80
  • RUM 0.10
  • Stochastic Oscillator
  • PRCT 44.05
  • RUM 18.10

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: